Outlook Therapeutics, Inc. (OTLK): SCHEDULE 13D/A filed Jan 22, 2025

Form type

SCHEDULE 13D/A

Filing date

Jan 22, 2025

Accession number

0000947871-25-000063

Filer

Outlook Therapeutics, Inc. (CIK 1649989)